Repository logo
  • Log In
    Log in via Symplectic to deposit your publication(s).
Repository logo
  • About
  • Communities & Collections
  • Advanced Search
  • Statistics
  • Log In
    Log in via Symplectic to deposit your publication(s).
  1. Home
  2. Faculty of Engineering
  3. Faculty of Engineering
  4. An integrated biorefinery concept for conversion of sugar beet pulp into value-added chemicals and pharmaceutical intermediates
 
  • Details
An integrated biorefinery concept for conversion of sugar beet pulp into value-added chemicals and pharmaceutical intermediates
File(s)
c7fd00094d.pdf (969.55 KB)
Published version
Author(s)
Cardenas-Fernandez, Max
Bawn, Maria
Hamley-Bennett, Charlotte
Bharat, Penumathsa KV
Subrizi, Fabiana
more
Type
Journal Article
Abstract
Over 8 million tonnes of sugar beet are grown annually in the UK. Sugar beet pulp (SBP) is the main by-product of sugar beet processing which is currently dried and sold as a low value animal feed. SBP is a rich source of carbohydrates, mainly in the form of cellulose and pectin, including D-glucose (Glu), L-arabinose (Ara) and D-galacturonic acid (GalAc). This work describes the technical feasibility of an integrated biorefinery concept for the fractionation of SBP and conversion of these monosaccharides into value-added products. SBP fractionation is initially carried out by steam explosion under mild conditions to yield soluble pectin and insoluble cellulose fractions. The cellulose is readily hydrolysed by cellulases to release Glu that can then be fermented by a commercial yeast strain to produce bioethanol at a high yield. The pectin fraction can be either fully hydrolysed, using physico-chemical methods, or selectively hydrolysed, using cloned arabinases and galacturonases, to yield Ara-rich and GalAc-rich streams. These monomers can be separated using either Centrifugal Partition Chromatography (CPC) or ultrafiltration into streams suitable for subsequent enzymatic upgrading. Building on our previous experience with transketolase (TK) and transaminase (TAm) enzymes, the conversion of Ara and GalAc into higher value products was explored. In particular the conversion of Ara into L-gluco-heptulose (GluHep), that has potential therapeutic applications in hypoglycaemia and cancer, using a mutant TK is described. Preliminary studies with TAm also suggest GluHep can be selectively aminated to the corresponding chiral aminopolyol. The current work is addressing the upgrading of the remaining SBP monomer, GalAc, and the modelling of the biorefinery concept to enable economic and Life Cycle Analysis (LCA).
Date Issued
2017-04-26
Date Acceptance
2017-03-30
Citation
Faraday Discussions, 2017, 202, pp.415-431
URI
http://hdl.handle.net/10044/1/57174
DOI
https://www.dx.doi.org/10.1039/c7fd00094d
ISSN
1359-6640
Publisher
Royal Society of Chemistry
Start Page
415
End Page
431
Journal / Book Title
Faraday Discussions
Volume
202
Copyright Statement
© The Royal Society of Chemistry 2017. This Open Access Article is licensed under a Creative Commons Attribution 3.0 Unported Licence (https://creativecommons.org/licenses/by/3.0/)
Sponsor
Engineering & Physical Science Research Council (E
Identifier
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000411412300025&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
Grant Number
EGNC
Subjects
Science & Technology
Physical Sciences
Chemistry, Physical
Chemistry
CENTRIFUGAL PARTITION CHROMATOGRAPHY
CHIRAL AMINO-ALCOHOLS
ENZYMATIC SACCHARIFICATION
BIOCATALYTIC SYNTHESIS
ONE-POT
TRANSKETOLASE
OPTIMIZATION
FRACTIONATION
ARABINOSE
COLI
Publication Status
Published
About
Spiral Depositing with Spiral Publishing with Spiral Symplectic
Contact us
Open access team Report an issue
Other Services
Scholarly Communications Library Services
logo

Imperial College London

South Kensington Campus

London SW7 2AZ, UK

tel: +44 (0)20 7589 5111

Accessibility Modern slavery statement Cookie Policy

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback